Clinical Trials Logo
  1. Home
  2. Oral Contraceptive
  3. NCT01291004

A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives

Oral Contraceptive Clinical Trial

Official title:
A Multicenter, Open-Label Study to Evaluate Ovarian Follicular Activity and Hormone Levels With the Oral Contraceptive Regimen DR-102 Compared to Two 28-day Oral Contraceptive Regimens Containing Different Synthetic Progestins

Clinical Trial Summary

This study is being conducted to evaluate the impact of a 28-day oral contraceptive compared to two 28-day oral contraceptive regimens containing different synthetic progestins on ovarian follicular activity and hormone levels in healthy women.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01291004
Study type Interventional
Source Teva Branded Pharmaceutical Products R&D, Inc.
Contact
Status Completed
Phase Phase 1
Start date January 31, 2011
Completion date March 31, 2012
View Details
See also
  Status Clinical Trial Phase
Completed NCT01388491 - A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women Phase 2
Completed NCT01252186 - A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women Phase 2
Recruiting NCT02398903 - Evaluation of Hormonal Contraceptive Treatments in Obese Women
Completed NCT00302666 - Bleeding Pattern Study Phase 3
Completed NCT00739622 - TMC278-TiDP6-C136: Effect of TMC278 on Ethinylestradiol and Norethindrone in Healthy Women. Phase 1
Recruiting NCT01318005 - Oral Contraceptive (OC) Estrogen Dose and Breast Proliferation N/A
Recruiting NCT02021097 - Study Evaluating Levonorgestrel and Ethinyl Estradiol for Oral Contraception Phase 3
Completed NCT00778609 - Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache Phase 3
Completed NCT00972439 - Oral Contraceptive (OC) Progestin Dose and Breast Proliferation N/A
Completed NCT01076582 - Comparative Trial in Hormone Withdrawal Associated Symptoms Phase 3
Completed NCT00471991 - Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation Inhibition Phase 2
Completed NCT00248963 - Study Evaluating Levonorgestrel and Ethinyl Estradiol in Oral Contraception Phase 3